Gregory J. Divis
CEO & DirectorMr. Gregory J. Divis, Jr. also known as Greg, is CEO & Director of Mentari Therapeutics, Inc. from July 20, 2026. Mr. Divis had been Director of Avadel Pharmaceuticals plc since June 3, 2019 until February 12, 2026 and had been its Chief Executive Officer since June 2019 until February 12, 2026. Mr. Divis served as an Interim Chief Executive Officer at Avadel Pharmaceuticals plc since January 2019 until June 3, 2019. Mr. Divis served as Chief Operating Officer and Executive Vice President at Avadel Pharmaceuticals plc since March 22, 2018 until December 2018. Mr. Divis is President at Avadel Management Corporation. Mr. Divis served as Chief Commercial Officer at Avadel Pharmaceuticals plc (Also known as Flamel Technologies SA) since January 3, 2017. Prior to Avadel Mr. Divis served as an Executive-in-Residence and Operating Partner for Linden Capital Partners from June 2015 to December 2016, a healthcare-focused middle market private equity firm. Previous roles also include Chief Executive Officer and President of Lumara Health (formerly K-V Pharmaceutical Company) from May 2010 to November 2014. Mr. Divis has also held such notable roles as Vice President, Business Development Lifecycle Management at Sanofi-Aventis and Vice-President and General Manager, UK and Ireland, for Schering-Plough Corporation. Mr. Divis serves on the Board of Directors of Mobius Therapeutics and previously served on the Board of Tolero Pharmaceuticals. Mr. Divis had been Director of Jaguar Health, Inc. since June 2018 until July 01, 2022. Mr. Divis served as the Chief Executive Officer and President of K-V Pharmaceutical Company since November 17, 2010 and served as its Interim President from June 10, 2010 to November 17, 2010. Mr. Divis served as President of Nesher Pharmaceuticals Inc. Mr. Divis served as the President of DrugTech Corporation and K-V Generic Pharmaceuticals, Inc. Mr. Divis served as the President of Ther-Rx Corporation, a wholly owned subsidiary of K-V Pharmaceutical Company from July 2007 to November 2010. Mr. Divis served as an Interim Chief Executive Officer at K-V Pharmaceutical Company from July 10, 2010 to November 17, 2010. Mr. Divis served as Vice President of Business Development and Life Cycle Management at Sanofi-aventis U.S., from February 2006 to July 2007. Mr. Divis served as Vice President of Sales, Respiratory East at Sanofi-aventis U.S., from June 2004 to February 2006. Mr. Divis served as an Executive Director of Sales and Marketing National Accounts at Reliant Pharmaceuticals from December 2003 to June 2004. Mr. Divis served as Vice President and Country Manager, United Kingdom and Ireland at Schering-Plough from May 2002 to December 2003. Mr. Divis served as Vice President of Field Operations, Oncology-Biotech Division at Schering-Plough from October 2000 to April 2002. Mr. Divis has been of K-V Pharmaceutical Company since September 16, 2013. Mr. Divis is a Director of Lumara Health, Inc. Mr. Divis has extensive experience in the pharmaceutical industry. Mr. Divis holds a Bachelor’s Degree from University of Iowa.
Positions
- Company NameMentari Therapeutics, Inc.Stock CodeMTRIPositionCEO & DirectorColleagues
- JBJulianne BrunoIndependent Chairperson of the Board
- BRBrett R. HagenCAO & Senior VP of Finance
- KNKelly NeelonChief Technical Officer
- JGJerad G. SeurerGeneral Counsel & Corporate Secretary
- AKAmanda KunevichChief People Officer
- LSLaura SandlerIndependent Director
- MPMichelle PerniceIndependent Director
- TETodd E. ShegogIndependent Director
